Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)
<h4>Objectives</h4> <p>o evaluate the efficacy of etanercept and methotrexate as monotherapies and as combination therapy in subjects with active psoriatic arthritis (PsA).</p> <h4>Methods</h4> <p>he Study of Etanercept and Methotrexate in Combination or as...
Main Authors: | Mease, P, Gladman, D, Samad, A, Coates, L, Liu, L, Aras, G, Collier, D, Chung, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2018
|
Similar Items
-
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
by: Coates, L, et al.
Published: (2020) -
Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
by: Helliwell, PS, et al.
Published: (2022) -
A randomized, phase 3, double-blind trial examining methotrexate and etanercept as monotherapy or in combinstion for treating psoriatic arthritis: A comparison of the composite measures used to evaluate disease activity
by: Mease, PJ, et al.
Published: (2019) -
Methotrexate in psoriasis and psoriatic arthritis
by: Coates, L, et al.
Published: (2020) -
Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
by: Nash, P, et al.
Published: (2020)